Drug Shortage Report for ISOFLURANE USP
| Report ID | 234160 |
| Drug Identification Number | 02231929 |
| Brand name | ISOFLURANE USP |
| Common or Proper name | ISOFLURANE USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ISOFLURANE |
| Strength(s) | 99.9% |
| Dosage form(s) | LIQUID |
| Route of administration | INHALATION INHALATION |
| Packaging size | 250 mL |
| ATC code | N01AB |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-07-30 |
| Estimated end date | 2024-08-28 |
| Actual end date | 2024-08-09 |
| Shortage status | Resolved |
| Updated date | 2024-08-10 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on the below Isoflurane USP 99.9% product formats effective July 30, 2024, until August 28, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-08-10 | English | Compare |
| v4 | 2024-08-09 | French | Compare |
| v3 | 2024-08-09 | English | Compare |
| v2 | 2024-07-31 | French | Compare |
| v1 | 2024-07-31 | English | Compare |
Showing 1 to 5 of 5